These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32682887)

  • 1. Clinical, histopathologic, and molecular profiles of PRKAR1A-inactivated melanocytic neoplasms.
    Williams EA; Shah N; Danziger N; Montesion M; Sokol ES; Pavlick DC; Miller VA; Ross JS; Elvin JA; Tse JY
    J Am Acad Dermatol; 2021 Apr; 84(4):1069-1071. PubMed ID: 32682887
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and Clinicopathologic Characteristics of PRKAR1A-inactivated Melanomas: Toward Genetic Distinctions of Animal-type Melanoma/Pigment Synthesizing Melanoma.
    Cohen JN; Yeh I; Mully TW; LeBoit PE; McCalmont TH
    Am J Surg Pathol; 2020 Jun; 44(6):805-816. PubMed ID: 32118628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-kit expression of melanocytic neoplasm and association with clinicopathological parameters and anatomic locations in Chinese people.
    Lin YC; Chang YM; Ho JY; Lin HC; Tsai YM; Chiang CP; Wang WM; Gao HW
    Am J Dermatopathol; 2013 Jul; 35(5):569-75. PubMed ID: 23221472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesions.
    Cesinaro AM; Natoli C; Grassadonia A; Tinari N; Iacobelli S; Trentini GP
    J Invest Dermatol; 2002 Jul; 119(1):187-90. PubMed ID: 12164944
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cutaneous melanocytic tumors. Case 2].
    Castillo C
    Ann Pathol; 2016 Oct; 36(5):322-325. PubMed ID: 27639774
    [No Abstract]   [Full Text] [Related]  

  • 7. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)].
    de la Fouchardière A; Vergier B
    Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446
    [No Abstract]   [Full Text] [Related]  

  • 8. Melanocytic lesions: current state of knowledge.
    Zembowicz A; Prieto VG
    Arch Pathol Lab Med; 2010 Dec; 134(12):1738-9. PubMed ID: 21128769
    [No Abstract]   [Full Text] [Related]  

  • 9. Value of dopachrome tautomerase detection in the assessment of melanocytic tumors.
    Filimon A; Zurac SA; Milac AL; Sima LE; Petrescu SM; Negroiu G
    Melanoma Res; 2014 Jun; 24(3):219-36. PubMed ID: 24709887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAFV600E mutation in oral melanocytic nevus and oral mucosal melanoma.
    Resende TAC; de Andrade BAB; Bernardes VF; Coura BP; Delgado-Azãnero W; Mosqueda-Taylor A; de Almeida OP; Gomes CC; Gomez RS
    Oral Oncol; 2021 Mar; 114():105053. PubMed ID: 33189579
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of oncogenes and growth factors in progressive melanoma-genesis.
    Albino AP
    Pigment Cell Res; 1992; Suppl 2():199-218. PubMed ID: 1409423
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dysplastic nevus syndrome, familial predisposition toward getting melanomas].
    van den Berg WH; Neering H
    Ned Tijdschr Geneeskd; 1981 Nov; 125(48):1969-71. PubMed ID: 7312070
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
    Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
    Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular genetics of Carney complex.
    Rothenbuhler A; Stratakis CA
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):389-99. PubMed ID: 20833331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanocytic nevi and melanoma: unraveling a complex relationship.
    Damsky WE; Bosenberg M
    Oncogene; 2017 Oct; 36(42):5771-5792. PubMed ID: 28604751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma arising in a nevus of Ito: novel genetic mutations and a review of the literature on cutaneous malignant transformation of dermal melanocytosis.
    Tse JY; Walls BE; Pomerantz H; Yoon CH; Buchbinder EI; Werchniak AE; Dong F; Lian CG; Granter SR
    J Cutan Pathol; 2016 Jan; 43(1):57-63. PubMed ID: 26260725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous melanoma arising in agminated melanocytic nevi: CDKN2A and CDK4 mutation screening.
    Rezze GG; Leon A; Silva DC; Neves RI; Molina GC; Carraro DM; Landman G; Duprat JP
    Acta Derm Venereol; 2012 Jan; 92(1):98-9. PubMed ID: 21710107
    [No Abstract]   [Full Text] [Related]  

  • 18. Epithelioid and fusiform blue nevus of chronically sun-damaged skin, an entity distinct from the epithelioid blue nevus of the Carney complex.
    Yazdan P; Haghighat Z; Guitart J; Gerami P
    Am J Surg Pathol; 2013 Jan; 37(1):81-8. PubMed ID: 22892599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA mismatch repair enzyme hMSH2 in malignant melanoma: increased immunoreactivity as compared to acquired melanocytic nevi and strong mRNA expression in melanoma cell lines.
    Rass K; Gutwein P; Welter C; Meineke V; Tilgen W; Reichrath J
    Histochem J; 2001 Aug; 33(8):459-67. PubMed ID: 11931386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Analysis of Pigmented Epithelioid Melanocytomas Reveals Recurrent Alterations in PRKAR1A, and PRKCA Genes.
    Cohen JN; Joseph NM; North JP; Onodera C; Zembowicz A; LeBoit PE
    Am J Surg Pathol; 2017 Oct; 41(10):1333-1346. PubMed ID: 28796000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.